Bokemeyer, C

Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. [electronic resource] - Journal of the National Cancer Institute Jan 1995 - 58-60 p. digital

Publication Type: Letter

0027-8874

10.1093/jnci/87.1.58 doi


Antineoplastic Combined Chemotherapy Protocols--adverse effects
Etoposide--administration & dosage
Humans
Leukemia--chemically induced
Male
Neoplasms, Second Primary--chemically induced
Testicular Neoplasms--drug therapy